MedCity News

FEBRUARY 5, 2025

Novo Nordisks monlunabant showed signs of neuropsychiatric side effects in a mid-stage diabetic kidney disease study, despite a drug design intended to favor hitting its target receptor in peripheral tissues rather than the brain. Neuro effects were also reported last year in a Phase 2 test of this pill in obesity. The post Oral Metabolic Drug Acquired by Novo Nordisk Continues to Show Concerning Neuro Side Effects appeared first on MedCity News.

Side effects 277

Side effects Biopharma Pharma 277

Evolve Your Success

FEBRUARY 5, 2025

From navigating the halls of Abbott Laboratories and Knoll Pharmaceutical Company to pioneering his path as an independent medical device sales rep, Bruce Brown’s career journey challenges traditional sales wisdom. In this episode, he reveals the innovative strategies that helped him thrive in both worlds – including an ingenious FedEx tactic that changed his pharmaceutical sales game.

Sales 130

Sales Medical sales Pharma Medical 130

MedCity News

FEBRUARY 5, 2025

While new technologies may demonstrate clinical benefits in controlled settings, their true value is determined by how well they fit into existing healthcare workflows. The post Balancing Innovation and Risk in Healthtech appeared first on MedCity News.

Healthcare 184

Healthcare Healthcare 184

European Pharmaceutical Review

FEBRUARY 5, 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) is seeking feedback on its regulatory guidance for individualised mRNA cancer immunotherapies. This guidance aims to streamline access pathways for patients, without compromising on the safety of these personalised immunotherapies. These cancer vaccines are tailored to an individuals tumour, [so] they pose unique scientific questions on how they should be regulated, Julian Beach , MHRA Executive Director of Healthcare Quality and Acc

Food and Drug Administration 52

Food and Drug Administration Government Safety Medicine 52

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

PharmaTimes

FEBRUARY 5, 2025

Breast cancer therapy offers hope for patients at risk of recurrence

Patients 100

Patients 100

PharmaVoice

FEBRUARY 5, 2025

With assets under a knife and pipelines under a microscope, R&D programs are being overhauled to be more efficient and cost effective.

Pharma 100

Pharma 100

pharmaphorum

FEBRUARY 5, 2025

Novo Nordisk is expecting greater competition and pricing pressure in the obesity and diabetes sectors this year.

Competition 94

Competition Sales 94

PharmaTech

FEBRUARY 5, 2025

The transaction is expected to enhance Jabils development and commercial production of auto-injectors, pen injectors, inhalers, and on-body pumps.

Pharmaceutical 59

Pharmaceutical 59

pharmaphorum

FEBRUARY 5, 2025

Robert F Kennedy Jr has cleared a key obstacle in his bid to become the next HHS Secretary after the Senate Finance Committee voted in his favour.

80

80

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

Pharmaceutical Technology

FEBRUARY 5, 2025

X-Elio will supply 245GWh of clean energy annually to four pharmaceutical companies through its Lorca Solar project.

Pharmaceutical 59

Pharmaceutical 59

pharmaphorum

FEBRUARY 5, 2025

Despite a steep fall-off in sales of RSV vaccine Arexvy last year, GSK has raised its long-term sales forecast to 40 billion in 2031.

Sales 75

Sales 75

Pharmaceutical Commerce

FEBRUARY 5, 2025

The company cites a decline in sales and excess inventory as the main contributing factors.

Sales 59

Sales 59

pharmaphorum

FEBRUARY 5, 2025

The renaissance of Roche's refillable ophthalmic implant Susvimo has continued with FDA approval for use in patients with diabetic macular oedema

FDA 68

FDA Patients 68

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

Pharmaceutical Technology

FEBRUARY 5, 2025

While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth.

Specialization 59

Specialization Medicine Sales 59

pharmaphorum

FEBRUARY 5, 2025

Liva Healthcare has acquired Momenta to create one of the largest providers of digital healthy lifestyle services to the NHS in England

Healthcare 64

Healthcare Healthcare 64

Pharmaceutical Technology

FEBRUARY 5, 2025

Experts at the 2025 Clinical Trial Supply Europe conference will explore supply chain challenges and the impact of AI on trials.

59

59

Pharmaceutical Commerce

FEBRUARY 5, 2025

The latest news for pharma industry insiders.

Pharma 59

Pharma 59

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy

Pharmaceutical Technology

FEBRUARY 5, 2025

Valnevas chikungunya vaccine Ixchiq has been greenlit by the UKs MHRA, allowing the single-dose vaccine to be made available for adults.

59

59

Pharmaceutical Commerce

FEBRUARY 5, 2025

In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, shares how the imposed/pending trade tariffs impact pharma manufacturers.

Pharma 59

Pharma Manufacturing 59

Pharmaceutical Technology

FEBRUARY 5, 2025

Astellas Pharma has submitted an NDA to Japan's Ministry of Health, Labour and Welfare seeking conditional approval of ACP.

Pharma 59

Pharma 59

Pharmacy Times

FEBRUARY 5, 2025

The initiative will provide information about care models for specialists and clinical teams to improve patient outcomes in heart failure.

Education 57

Education Patients 57

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Pharmaceutical Technology

FEBRUARY 5, 2025

MedPharm has appointed Bill Humphries as its new CEO, marking a significant step in the company's strategic growth.

59

59

PharmaTech

FEBRUARY 5, 2025

Webinar Date/Time: Tues, March 4, 2025 11:00 AM EST

Pharma 52

Pharma 52

Pharmaceutical Technology

FEBRUARY 5, 2025

During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a detailed review of its achievements in 2024 and outlining its 2025 plans.

Healthcare 59

Healthcare Healthcare 59

Pharma Marketing Network

FEBRUARY 5, 2025

Table of Contents Sr# Headings 1 Understanding Pharmaceutical Market Access 2 Challenges in Pharmaceutical Market Access 3 Key Strategies for Market Access Success 4 Emerging Trends Shaping Market Access Understanding Pharmaceutical Market Access Bringing a new drug to market is only part of the battle. The real challenge lies in ensuring it reaches the right patients at the right time and at an affordable price.

Marketing 52

Marketing Pharmaceutical Pharma Insurance 52

Advertiser: ZoomInfo

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

Prospecting

Pharmaceutical Technology

FEBRUARY 5, 2025

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).

Manufacturing 59

Manufacturing Pharmaceutical 59

Pharma Marketing Network

FEBRUARY 5, 2025

Table of Contents Sr# Headings 1 Understanding Programmatic Advertising Platforms 2 Why Pharma Marketers Need Programmatic Advertising 3 Key Challenges and Compliance Considerations 4 The Future of Programmatic Advertising in Pharma Understanding Programmatic Advertising Platforms Pharma marketing has evolved dramatically, and programmatic advertising platforms are at the forefront of this transformation.

Marketing 52

Marketing Pharma Healthcare Healthcare 52

PharmExec

FEBRUARY 5, 2025

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI compares and discusses the potential impact of AI-driven drug discovery platforms.

Pharmaceutical 52

Pharmaceutical 52